Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rang in Aktien #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Aktienkurs
$2.03
Marktkapitalisierung
$121.44M
Veränderung (1 Tag)
-0.93%
Veränderung (1 Jahr)
-1.97%
Land
FR
Handel Crossject Société Anonyme (ALCJ)

Kategorie

Kursverlauf für Crossject Société Anonyme (ALCJ)
Höchster Schlusskurs: $2.04 am 2026-07-01

Niedrigster Schlusskurs: $14.25 am 2014-02-01
Kursverlauf der Aktie von Crossject Société Anonyme von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 11.08%
2025 -0.35%
2024 -57.35%
2023 37.09%
2022 20.21%
2021 -26.70%
2020 75.54%
2019 63.37%
2018 -70.52%
2017 2.47%
2016 -46.89%
2015 -15.92%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$406.78 -20.56%
US
$200.93 -28.84%
FR
$55.43 6.36%
DE
$155.72 28.74%
JP
$151.94 -13.66%
US